# HongShan Capital

HongShan Capital Group (HSG), formerly Sequoia Capital China, is a global venture capital and private equity firm founded in 2005, managing around $56 billion in assets and investing in sectors like AI, healthcare, and consumer.

HongShan Capital Group (HSG; Chinese: 红杉中国; pinyin: Hóngshān Zhōngguó) is a global venture capital and private equity firm founded in 2005. It was previously the China investment arm of Sequoia Capital and was known as Sequoia Capital China before being rebranded and spun off as a separate entity in 2023. The firm manages approximately $56 billion in assets and has offices in Hong Kong, Beijing, Shanghai, London, Singapore, Shenzhen, and Tokyo.

HongShan has expanded its focus beyond early-stage investing to also cover growth stage, infrastructure, healthcare, consumer, and buyout funds. It has made notable investments in technology companies, including artificial intelligence startups such as Zhipu AI and MiniMax.

## Background

### Sequoia Capital China (2005 to 2023)

In 2005, Neil Shen and Zhang Fan co-founded Sequoia Capital China with the guidance of Sequoia partners Michael Moritz and Douglas Leone. The two were selected by Sequoia to lead the firm's venture in China. In 2009, Zhang resigned for personal reasons, leaving Shen in charge of operations. By that period, the firm had raised a combined $1 billion for three U.S. dollar-denominated China funds and 1 billion yuan for a local currency fund.

Sequoia China subsequently raised more capital, mostly from US institutional investors, and built a successful investment record that included companies such as Alibaba Group, JD.com, Meituan, Pinduoduo, Shein, and ByteDance. Historically, 90% of returns came from consumer, consumer tech, and healthcare fields. By 2023, Sequoia China had invested in over 1,000 projects. In 2021, the firm acquired a controlling stake in the French fashion brand Ami Paris.

In June 2023, Sequoia announced it would split off Sequoia China as a separate entity, a process completed by 31 March 2024. This came amid rising tensions in China–United States relations, though Sequoia denied that tensions were the reason. Sequoia China was rebranded as HongShan (a pinyin romanisation of its Chinese name, meaning redwood) in English, while its Chinese name remained the same. Going forward, the firm would raise capital as a Chinese venture capital firm rather than as the Chinese arm of an American firm.

### HongShan (2023 to present)

In July 2023, HongShan announced it had set up an office in Singapore, planning to use it as a base for Southeast Asian investments. Speculation arose that it would compete with Peak XV Partners, the Indian and Southeast Asian investment arm of Sequoia that was also split off. HongShan stated there were no plans to open an office in the US.

In October 2023, the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party asked Sequoia to provide details about investments in artificial intelligence and other high-tech sectors made by it and HongShan. Members questioned whether the split would insulate capital flows from US regulatory scrutiny, noting that HongShan relied on limited partners and that US institutional investors could continue investing. They also accused HongShan of funnelling US capital into investments that contributed to human rights abuses and military modernisation, citing examples like DeepGlint and ByteDance. Additional requests included identifying limited partners domiciled in China or managing funds for state-owned entities, and confirming the number of US limited partners. US limited partners were not targeted, and institutional investors remained confident they could continue relationships after the US Treasury finalises outbound investment restrictions.

In November 2023, despite scrutiny, new investors signed on with HongShan, including CalPERS and University of Washington Investment Management. Existing investors such as CPP Investment Board and Regents of the University of California added commitments. In July 2024, HongShan raised its first new fund as a separate entity, securing 18 billion RMB ($2.5 billion) for startup investments. In October 2024, it set up a London office to seek European opportunities. In November 2024, reports indicated HongShan was struggling to deploy its large cash pile in a sluggish domestic market and tightening US controls.

In 2025, HSG acquired a majority stake in the audio equipment maker Marshall Group in a $1.1 billion deal, its largest European investment. HSG opened a Tokyo office in February 2025. In September 2025, HSG was shortlisted with EQT, The Carlyle Group, and Boyu Capital to bid for a controlling stake in Starbucks' China operations. In October 2025, Bayer AG was reported to be selling its global Avelox antibiotics business to HSG. In December 2025, HSG acquired a majority stake in Italian luxury fashion company Golden Goose.

In August 2026, Bloomberg reported that HSG had held preliminary talks to raise at least $1.2 billion for an early-stage fund targeting artificial intelligence, healthcare, and consumer companies. This would be the firm's first dollar-denominated vehicle since its separation from Sequoia Capital.

## Investment Focus and AI

HongShan has increasingly focused on [artificial-intelligence](https://www.wikiprompt.org/wiki/artificial-intelligence) investments, backing companies such as Zhipu AI, a [large-language-model](https://www.wikiprompt.org/wiki/large-language-model) developer, and MiniMax, a generative AI startup. These investments align with the firm's broader strategy of supporting technology innovation in China and globally. The firm's AI portfolio spans [machine-learning](https://www.wikiprompt.org/wiki/machine-learning) and [generative-ai](https://www.wikiprompt.org/wiki/generative-ai) applications, reflecting its interest in cutting-edge technologies.

## Global Expansion

HongShan's expansion into Singapore, London, and Tokyo signals its ambition to diversify beyond China. The Singapore office serves as a hub for Southeast Asia, while the London office targets European opportunities. The Tokyo office, opened in 2025, aims to tap into Japanese technology and consumer markets. These moves come as the firm navigates geopolitical tensions and regulatory scrutiny from US lawmakers.

## Governance and Scrutiny

HongShan's separation from Sequoia has drawn attention from US regulators and lawmakers. The firm's reliance on US institutional investors has raised questions about capital flows and national security. Despite this, HongShan continues to attract new investors and raise funds, indicating resilience in the face of political pressure. The firm's ability to deploy capital in a challenging domestic market remains a key focus.

## References

This article is based on publicly available information and reports as of August 2026.

---
Source: https://www.wikiprompt.org/wiki/hongshan-capital
License: CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/)
Last updated: 2026-09-13T03:58:13.7762+00:00